Evidence mapPaperPMID 41320769Full record

ArticleMaternal health, neonatology and perinatology2025

Impact of non-communicable diseases on maternal and perinatal outcomes in a low resource setting.

Leevan Tibaijuka, Adeline A Boatin, Yarine Fajardo Tornes, Asiphas Owaraganise, Musa Kayondo, Hamson Kanyesigye, Esther C Atukunda, Lisa M Bebell, Francis Bajunirwe, Jean-Pierre Van Geertruyden and 2 more

Abstract read
In one paragraph

Article in Maternal health, neonatology and perinatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Leevan TibaijukaDepartment of Obstetrics and Gynecology, Mbarara Regional Referral Hospital, Mbarara, Uganda. ltibaijuka@must.ac.ug.
Adeline A BoatinDepartment of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Yarine Fajardo TornesDepartment of Obstetrics and Gynecology, Faculty of Medicine, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Asiphas OwaraganiseInfectious Diseases Research Collaboration, Kampala, Uganda.
Musa KayondoDepartment of Obstetrics and Gynecology, Faculty of Medicine, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Hamson KanyesigyeDepartment of Obstetrics and Gynecology, Faculty of Medicine, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Esther C AtukundaDepartment of Pharmacy, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Lisa M BebellDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Francis BajunirweDepartment of Community Health, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Jean-Pierre Van GeertruydenGlobal Health Institute, University of Antwerp, Antwerp, Belgium.
Yves JacquemynGlobal Health Institute, University of Antwerp, Antwerp, Belgium.
Joseph NgonziDepartment of Obstetrics and Gynecology, Faculty of Medicine, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.

Funding

Integration of a patient-centered mobile health intervention (Support-Moms) into routine antenatal care to improve maternal health in UgandaR01HD111692 · NICHD · MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY · PI Esther Cathyln Atukunda · 2023 to 2026
$1.9M
Multi-morbidity in Uganda Research Capacity Initiative (MURCI) at Mbarara University of Science and TechnologyD43TW011632 · FIC · MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY · PI BAJUNIRWE, FRANCIS · 2020 to 2024
$1.2M
FIC NIH HHS D43 TW011632NICHD NIH HHS R01 HD111692The Multi-morbidity Research Capacity Initiative (MURCI) research training fellowship supported by the Fogarty International Centre of the National Institute of Health Award number D43TW011632
6 · The paper itself

Abstract

backgroundNon-communicable diseases (NCDs) are increasingly prevalent among women of reproductive age and may pose significant risks to maternal and perinatal health. Despite their growing burden, data on their impact in low-resource settings remains limited. This study aimed to investigate the impact of pre-pregnancy NCDs on severe maternal and adverse perinatal outcomes among pregnant women admitted at Mbarara Regional Referral Hospital (MRRH) in southwestern Uganda.

methodsWe prospectively enrolled pregnant women admitted to the maternity ward of MRRH from July 2022 to October 2023. We consecutively included all women with one or more NCDs and next two admissions without NCDs. Baseline sociodemographic and clinical documentation of pre-pregnancy NCDs including chronic hypertension, pre-gestational diabetes, cardiac disease, chronic kidney disease, sickle cell disease, asthma, and epilepsy. Participants were followed from admission through delivery, puerperium, and post-discharge with phone calls at 2, 4, and 6 weeks, and severe maternal and adverse perinatal outcomes were documented. We compared outcomes between women with and without NCDs and performed multivariable logistic regression analyses to determine the association between NCDs and these outcomes, adjusting for potential confounders, including maternal age, gravidity, employment status, HIV serostatus and delivery mode.

resultsWe enrolled a cohort of 300 pregnant women (100 with NCDs and 200 without NCDs) with a mean age of 27.8 ± 5.9 years. Severe maternal outcomes occurred in 80/300 participants (26.7%), with a significantly higher incidence among those with NCDs (36.0%, n = 36/100) compared to those without (22.0%, n = 44/200), including maternal death (4.0%, n = 4 vs. 0.5%, n = 1), acute heart failure (7.0%, n = 7 vs. 0%), ICU admission (9.0%, n = 9 vs. 2.0%, n = 4), pulmonary embolism (4.0%, n = 4 vs. 0%) and sepsis (7.0%, n = 7 vs. 1.0%, n = 2). At least one adverse perinatal outcome occurred in most participants (52.7%, n = 158/300). Women with NCDs also experienced significantly higher rates of adverse perinatal outcomes (69.0%, n = 69/100) than those without NCDs (44.5%, n = 89/200), including miscarriage (11.0%, n = 11 vs. 1.0%, n = 2), neonatal death (11.5%, n = 9 vs. 4.5%, n = 8), and NICU admission (48.7%, n = 38 vs. 20.3%, n = 36). In multivariable analysis, having one or more pre-pregnancy NCD (adjusted odds ratio [aOR]: 2.02, 95% CI [1.10, 3.68]) and attending fewer than four antenatal care (ANC) visits (aOR: 2.25, 95% CI [1.26, 4.04]) were significantly associated with increased risk of both severe maternal and adverse perinatal outcomes (NCDs: aOR: 2.39, 95% CI [1.34, 4.26]; <4 ANC visits: aOR: 1.95, 95% CI [1.12, 3.38]).

conclusionsPre-pregnancy NCDs and inadequate antenatal care are linked to severe maternal and adverse perinatal outcomes. Strengthening early identification, integrating NCD management into routine maternal care, and ensuring adequate antenatal visit coverage are critical to mitigating these risks. These findings underscore the need for targeted, multidisciplinary interventions to improve outcomes in resource-limited settings.

Indexed as

Adverse perinatal outcomesLow-resource settingMaternal mortalityPre-pregnancy non-communicable diseasesSevere maternal morbiditySevere maternal outcomesSub-Saharan Africa

Identifiers

PMID41320769
PMCPMC12667103

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.